Plant allergens are proteins found in various parts of plants that can elicit allergic reactions in susceptible individuals. Common sources of plant allergens include pollen, fruits, vegetables, nuts, and seeds. Allergic responses to plant allergens can manifest as respiratory symptoms (hay fever), skin reactions, or gastrointestinal issues. Pollen allergens, prevalent during specific seasons, contribute to hay fever or allergic rhinitis. Cross-reactivity between certain pollens and proteins in fruits or vegetables can lead to oral allergy syndrome (OAS), causing itching or swelling in the mouth and throat. Prominent plant allergens include proteins like profilins, lipid transfer proteins (LTPs), and pathogenesis-related proteins. Sensitization to these allergens can occur through inhalation, ingestion, or skin contact. Management of plant allergies involves allergen avoidance, symptomatic relief with antihistamines or corticosteroids, and in severe cases, allergen immunotherapy. Ongoing research focuses on understanding the molecular basis of plant allergies, improving diagnostic methods, and exploring potential therapeutic interventions to alleviate symptoms and enhance the quality of life for individuals affected by plant allergens.
Khursheed Anwer
IMUNON, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Khursheed Anwer
IMUNON, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Lara Isis Teodoro
Mayo Clinic, United States
Ahmed Abdulazeez
BHRUT Trust, United Kingdom
Elena Chiappini
University of Florence, ItalySubmit your abstract Today
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe